Sign in
Not yet taking people in United StatesPhase 4

Testing indocyanine green dye to spot the ureter during endometriosis surgery

Tests indocyanine green dye to help find the ureter during robot-assisted surgery for advanced endometriosis.

Key facts

Who runs it
Baylor College of Medicine
Where
Houston, United StatesSee the site
Trial code
Registry title
Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis
Status
Not yet recruiting
Phase
Phase 4
People taking part
40 people, planned
Started
1 Oct 2025
Planned end
15 Mar 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Indocyanine Green (ICG)-Assisted Ureteral Identification
  • Standard Ureteral Identification without ICG
Record updated
28 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult women with advanced endometriosis who are planned for robotic surgery to remove it. It tests a green dye (indocyanine green) to help the surgeon see the ureter during the operation.

Age
18 years or older
Sex
Women only
Disease stage
Stage III or IV endometriosis (rASRM classification)
Earlier treatment
Planned robotic transabdominal endometriosis excision, with or without hysterectomy

Main reasons for not taking part

  • Younger than 18 years old
  • Pregnant
  • Prisoners
  • Mental disabilities or cognitive impairment

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Stage III or IV endometriosis (rASRM classification)
  • Planned robotic transabdominal endometriosis excision with or without hysterectomy

Who cannot take part

  • Subjects who are part of a vulnerable population will be excluded including those who are prisoners, younger than 18 years old, pregnant, individuals with mental disabilities or cognitive impairment

Where in United States

  • Texas Childrens Hospital Pavilion for WomenHouston, United StatesContact: Xiaoming Guan, PhD, MDNot yet recruiting

About the trial

What the trial wants to find out

The goal of this side-randomized, self-controlled trial, 1-site study is to explore the efficacy of Indocyanine Green Fluorescence (ICG) for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis.

Read full original descriptionShow less

Researchers will perform temporary ureteral stent using indocyanine green fluorescence for intraoperative ureteral identification on either the left or right side of subjects who are undergoing a robotic assisted transumbilical resection of advanced endometriosis.

Participants will be randomized to receive ICG-assisted ureteral identification on either the left or right side. Randomization will be conducted using a computer-generated block randomization method.

The primary aim is to determine whether ICG-assisted ureter visualization can reduce operative time for endometriosis resection and ureterolysis, and minimize the risk of ureteral injury.

Secondary objectives are to assess the feasibility and safety of temporary ureteral ICG stenting for intraoperative ureter identification in advanced endometriosis.

The 2 groups in the trial

  • Arm A: ICG-Assisted Ureteral Identification (Unilateral)Treatment being tested

    Participants assigned to this study will undergo intraoperative ureteral identification using indocyanine green (ICG) fluorescence imaging in either left or right side. A temporary ureteral stent will be inserted on the randomized side (left or right) prior to ureterolysis and endometriosis resection. ICG will be administered through the stent to facilitate real-time fluorescence visualization of the ureter during robot-assisted single-site surgery. The contralateral side will serve as the control arm (standard visualization without ICG).

    Treatment: Indocyanine Green (ICG)-Assisted Ureteral Identification

  • Arm B: Standard Visualization (Contralateral Control)Existing treatment, for comparison

    Participants assigned to this study will undergo intraoperative ureteral identification using indocyanine green (ICG) fluorescence imaging in either left or right side. A temporary ureteral stent will be inserted on the randomized side (left or right) prior to ureterolysis and endometriosis resection. ICG will be administered through the stent to facilitate real-time fluorescence visualization of the ureter during robot-assisted single-site surgery. The contralateral side will serve as the control arm (standard visualization without ICG).

    Treatment: Standard Ureteral Identification without ICG

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Side-Randomized, Self-Controlled Trial Assessing the Efficacy of Indocyanine Green Fluorescence Imaging for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis
Plain-language title
Testing indocyanine green dye to spot the ureter during endometriosis surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
28 August 2025